A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Childrens Cancer Study Group
- 1 August 1990
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 9 (1) , 69-76
- https://doi.org/10.1007/bf00167071
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comprehensive phase II evaluation of Aziridinylbenzoquinone (AZQ, Diaziquone) in recurrent human primary brain tumorsJournal of Neuro-Oncology, 1987
- Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A phase ii study by the illinois cancer councilCancer, 1985
- Phase I clinical evaluation of diaziquone in childhood cancer.1985
- Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant gliomaJournal of Neuro-Oncology, 1985
- Phase 11 study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiationJournal of Neuro-Oncology, 1985
- Treatment of patients with recurrent primary brain tumors with AZQNeurology, 1984
- PHASE-I STUDY OF AZIRIDINYLBENZOQUINONE (AZQ, NSC-182986) IN CHILDREN WITH CANCER1984
- A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumorsJournal of Neuro-Oncology, 1984
- Diaziquone (AZQ)Investigational New Drugs, 1983
- PHASE-II AND PHARMACOKINETIC STUDY OF AZIRIDINYLBENZOQUINONE [2,5-DIAZIRIDINYL-3,6-BIS(CARBOETHOXYAMINO)-1,4-BENZOQUINONE, DIAZIQUONE, NSC-182986] IN HIGH-GRADE GLIOMAS1983